Low frequency of common LRRK2 mutations in Mexican patients with Parkinson's disease

Neuroscience Letters

Volumn 485, Issue 2, 2010, Pages 79-82

  Yescas, Petra ^a   López, Marisol ^b   Monroy, Nancy ^a   Boll, Marie Catherine ^a   Rodríguez Violante, Mayela ^a   Rodríguez, Ulises ^a   Ochoa, Adriana ^a   Alonso, María Elisa ^a  

^a NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^b DEPARTAMENTO DE SISTEMAS BIOLÓGICOS   (Mexico)

Author keywords

LRRK2; Mexican mestizo population; Mutation; Parkinson's disease

Indexed keywords

LEUCINE RICH REPEAT KINASE 2;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; FEMALE; GENE FREQUENCY; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEXICO; PARKINSON DISEASE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MEXICO; MIDDLE AGED; MUTATION; PARKINSON DISEASE; PEDIGREE; PROTEIN-SERINE-THREONINE KINASES; YOUNG ADULT;

EID: 77957347508     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.08.029     Document Type: Article

References (26)

1. Belin A.C., Westerlund M., Sydow O., Lundströmer K., Håkansson A., Nissbrandt H., Olson L., Galter D. Leucine-rich repeat kinase 2 (LRRK2) mutations in a Swedish Parkinson cohort and a healthy nonagenarian. Mov. Disord. 2006, 21:1731-1734.
2. Berg D., Schweitzer K.J., Leitner P., Zimprich A., Lichtner P., Belcredi P., Brussel T., Schulte C., Maass S., Nägele T., Wszolek Z.K., Gasser T. Type and frequency of mutations in the LRRK2 gene in familial and sporadic Parkinson's disease. Brain 2005, 128(Pt. 12):3000-3011.
3. Biskup S., West A.B. Zeroing in on LRRK2-linked pathogenic mechanism in Parkinson's disease. Biochim. Biophys. Acta 2009, 1792:625-633.
4. Funuyama M., Hasegawa K., Ohta E., Kawashima N., Komiyama M., Kowa H., Tsuji S., Obata F. An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family. Ann. Neurol. 2005, 57:918-921.
5. Gómez M., Clark R.M., Nath S.K., Bhatti S., Sharma R., Alonso E., Rasmussen A., Bidichandani S.I. Genetic admixture of European FRDA genes is the cause of Friedreich ataxia in the Mexican population. Genomics 2004, 84:779-784.
6. Gorostidi A., Ruiz-Martínez J., López de Munain A., Alzualde A., Massó J.F. LRRK2 G2019S and R1441G mutations associated with Parkinson's disease are common in the Basque Country, but relative prevalence is determined by ethnicity. Neurogenetics 2009, 10:157-159.
7. Healy D.G, Falchi M., O'Sullivan S.S., Bonifati V., Durr A., Bressman S., Brice A., Aasly J., Zabetian C.P., Goldwurm S., Ferreira J.J., Tolosa E., Kay D.M., Klein C., Williams D.R., Marras C., Lang A.E., Wszolek Z.K., Berciano J., Schapira A.H.V., Lynch T., Bathia K.P., Gasser T., Lees A.J., Wood N.W. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case control study. Lancet Neurol. 2008, 7:583-590. on behalf of the International LRRK2 Consortium.
8. Hughes A.J., Daniel S.E., Ben-Shlomo Y., Lees A.J. The accuracy of diagnosis of Parkinsonian syndromes in a specialist movement disorder service. Brain 2002, 125:861-870.
9. Latourelle J.C., Sun M., Lew M.F., Suchowersky O., Klein C., Golbe L.I., Mark M.H., Growdon J.H., Wooten G.F., Watts R.L., Guttman M., Racette B.A., Perlmutter J.S., Ahmed A., Shill H.A., Singer C., Goldwurm S., Pezzoli G., Zini M., Saint-Hilaire M.H., Hendricks A.E., Williamson S., Nagle M.W., Wilk J.B., Massood T., Huskey K.W., Laramie J.M., DeStefano A.L., Baker K.B., Itin I., Litvan I., Nicholson G., Corbett A., Nance M., Drasby E., Isaacson S., Burn D.J., Chinnery P.F., Pramstaller P.P., Al-hinti J., Moller A.T., Ostergaard K., Sherman S.J., Roxburgh R., Snow B., Slevin J.T., Cambi F., Gusella J.F., Myers R.H. The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study. BMC Med. 2008, 6:32.
10. Lesage S., Brice A. Parkinsons's disease: from monogenic forms to genetic susceptibility factors. Hum. Mol. Genet. 2009, 18:R48-R59.
11. Lesage S., Durr A., Tazir M., Lohmann E., Leutenegger A.L., Janin S., Pollak P., Brice A. LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs. N. Engl. J. Med. 2006, 354:422-423.
12. Mata I.F., Taylor J.P., Kachergus J., Hulihan M., Huerta C., Lahoz C., Blazquez M., Guisasola L.M., Salvador C., Ribacoba R., Martinez C., Farrer M., Alvarez V. LRRK2 R1441G in Spanish patients with Parkinson's disease. Neurosci. Lett. 2005, 382:309-311.
13. Mata I.F., Cosentino C., Marca V., Torres L., Mazzetti P., Ortega O., Raggio V., Aljanati R., Buzo R., Yearout D., Dieguez E., Zabetian C.P. LRRK2 mutations in patients with Parkinson's disease from Peru and Uruguay. Parkinsonism Relat. Disord. 2009, 15:370-373.
14. Mata I.F., Hutter C.M., González-Fernández M.C., de Pancorbo M.M., Lezcano E., Huerta C., Blázquez M., Ribacoba R., Guisasola L.M., Salvador C., Gómez-Esteban J.C., Zarranz J.J., Infante J., Jankovic J., Deng H., Edwards K.L., Alvarez V., Zabetian C.P. Lrrk2 R1441G-related Parkinson's disease: evidence of a common founding event in the seventh century in Northern Spain. Neurogenetics 2009, 10:347-357.
15. Munhoz R.P., Wakutani Y., Marras C., Teive H.A., Raskin S., Werneck L.C., Moreno D., Sato C., Lang A.E., Rogaeva E. The G2019S LRRK2 mutation in Brazilian patients with Parkinson's disease: phenotype in monozygotic twins. Mov. Disord. 2008, 23:290-294.
16. Ozelius L.J., Senthil G., Saunders-Pullman R., Ohmann E., Deligtisch A., Tagliati M., Hunt A.L., Klein C., Henick B., Hailpern S.M., Lipton R.B., Soto-Valencia J., Risch N., Bressman S.B. LRRK2 G2019S as cause of Parkinson's disease in Ashkenazi Jews. N. Engl. J. Med. 2006, 354:424-425.
17. Paisán-Ruíz C., Jain S., Evans E.W., Gilks W.P., Simon J., van der Brug M., López de Munain A., Aparicio S., Martínez-Gil A., Khan N., Johnson J., Ruíz-Martínez J., Nicholl D., Martí I., Saenz A., de Silva R., Lees A., Martí-Massó J.F., Pérez-Tur J., Wood N.W., Singleton A.B. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 2004, 44:595-600.
18. Paisán-Ruíz C., Nath P., Washecka N., Gibbs J.R., Singleton A.B. Comprehensive analysis of LRRK2 in publicly available Parkinson's disease cases and neurologically normal controls. Hum. Mutat. 2008, 29:485-490.
19. Perez-Pastene C., Cobb S.A., Díaz-Frez F., Hulihan M.M., Miranda M., Venegas P., Trujillo O., Kachergus J.M., Ross O.A., Layson L., Farrer M.J., Segura-Aguilar J. Lrrk2 mutations in South America: a study of Chilean Parkinson's disease. Neurosci. Lett. 2007, 422:193-197.
20. Ross A.O., Spanaki C., Griffith A., Lin C.H., Kachergus J., Haugarvoll K., Latsoudis H., Plaitakis A., Ferreira J.J., Sampaio C., Bonifati V., Wu R.M., Zabetian C.P., Farrer M.J. Haplotype analysis of Lrrk2 R1441H carriers with parkinsonism. Parkinsonism Relat. Disord. 2009, 15:466-467.
21. Samii A., Nutt J.G., Ransom B.C., Parkinson's disease Lancet 2004, 363:1783-1793.
22. Simón-Sánchez J., Martí-Masso J.F., Sánchez-Mut J.V., Paisán-Ruiz C., Martínez-Gil A., Ruiz-Martínez J., Sáenz A., Singleton A.B., López de Munain A., Pérez-Tur J. Parkinson's disease due to the 1441 mutation in dardarin: a founder effect in the Basques. Mov. Disord. 2006, 21:1954-1959.
23. Tan E.K., Skipper L.M. Pathogenic mutations in Parkinson disease. Hum. Mutat. 2007, 28:641-653.
24. Zabetian C.P., Samii A., Mosley A.D., Roberts J.W., Leis B.C., Yearout D., Raskind W.H., Griffith A. A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations. Neurology 2005, 65:741-744.
25. Zimprich A., Biskup S., Leitner P., Lichtner P., Farrer M., Lincoln S., Kachergus J., Hulihan M., Uitti R.J., Calne D.B., Stoessl A.J., Pfeiffer R., Patenge N., Carbajal I.C., Vieregge P., Asmus F., Müller-Myhsok B., Dickson D.W., Meitinger T., Storm T.M., Wszolek Z.K., Gasser T. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 2004, 44:601-607.
26. Zimprich A., Müller-Myhsok B., Farrer M., Leitner P., Sharma M., Hulihan M., Lockhart P., Strongosky A., Kachergus J., Calne D.B., Stoessl J., Uitti R.J., Pfeiffer R.F., Trenkwalder C., Homann N., Ott E., Wenzel K., Asmus F., Hardy J., Wszolek Z., Gasser T. The PARK8 locus in autosomal dominant parkinsonism: confirmation of linkage and further delineation of the disease-containing interval. Am. J. Hum. Genet. 2004, 74:11-19.